CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-25 | MCGIRR DAVID W J Director | Grant or award · Stock Option | +22,500 | 65,780 | ||
| 2019-06-25 | Royston Aaron Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2019-06-25 | BERNS PAUL L Director | Grant or award · Stock Option | +22,500 | 65,780 | ||
| 2019-06-25 | Whitcup Scott M Director | Grant or award · Stock Option | +22,500 | 134,099 | ||
| 2019-06-25 | Ebel Ted Director | Grant or award · Stock Option | +22,500 | 53,423 | ||
| 2019-06-25 | MCGIRR DAVID W J Director | Grant or award · Stock Option | +22,500 | 65,780 | ||
| 2019-06-25 | Sandoval Elisabeth Director | Grant or award · Stock Option | +11,645 | 45,000 | ||
| 2019-06-17 | Krasnow Ronald A. | Grant or award · Stock Option | +130,000 | 130,000 | ||
| 2019-03-19 | Sandoval Elisabeth Director | Grant or award · Stock Option | +33,355 | 33,355 | ||
| 2019-01-14 | Whitcup Scott M Director | Exercise or conversion · Stock Option | −25,000 | $1.83 | $46K | 77,043 |
| 2018-12-10 | Spellman Mary Chief Medical Officer | Grant or award · Stock Option | +96,000 | 96,000 | ||
| 2018-12-10 | Kwon Paul Chief Scientific Officer | Grant or award · Stock Option | +64,000 | 64,000 | ||
| 2018-12-10 | BALL KRISTINE M SVP, Corporate Strategy & CFO | Grant or award · Stock Option | +96,000 | 96,000 | ||
| 2018-07-24 | Presidio Partners 2007 GP, L.P. Former 10% Owner | Sale | −487,500 | $7.65 | $3.7M | 1,907,568 |
| 2018-07-24 | Presidio Partners 2007 GP, L.P. Former 10% Owner | Sale | −12,500 | $7.65 | $96K | 48,910 |
| 2018-05-03 | Kwon Paul Chief Medical Officer | Grant or award · Stock Option | +64,000 | 252,512 | ||
| 2018-05-03 | BALL KRISTINE M | Grant or award · Stock Option | +64,000 | 237,123 | ||
| 2018-05-03 | Basta Steven L Chief Executive Officer | Grant or award · Stock Option | +212,850 | 669,400 | ||
| 2018-03-02 | Presidio Partners 2007 GP, L.P. 10% owner | Other acquisition | +152,062 | 152,062 | ||
| 2018-01-29 | FMR LLC | Conversion | +813,478 | 813,478 |
Page 19 of 22 · 425 trades